This project will contribute information needed to describe and ultimately to understand one of the major stages in the expression of genetic information, namely, RNA splicing. We have generated antibodies for a novel branch structure (an RNA lariat) that is a key intermediate formed during intron removal from mRNA precursor molecules of eukaryotes. These antibodies will be used to develop assays that can detect and quantitate the RNA lariat intermediates that form during splicing in nuclear extracts. Antibodies will also be used to probe the lariat structures form from a variety of introns where differences in the branch consensus sequences exist. Anti-branch antibodies will be tested as specific inhibitors of splicing since they recognize the first product of the splicing reaction and would allow the separation of the two major steps of the splicing reaction. A second project will use RNA splicing to map introns in genomic DNA restriction fragments. The strategy depends on generating RNA from DNA fragments cloned into a transcription vector into which either intact 3' or 5' splice sites have been engineered. Two vectors will be designed, one supplying an intact 3' and another an intact 5' splice site. Each could complement an opposite splice site within the cloned genomic insert to produce a chimaeric RNA with a spliceable intron. An intact splice site inserted downstream from each of the independently activatable promoters in the transcription vector will reveal the strand of the cloned DNA that contains this splice site. An unrelated project will attempt to find specific proteins that bind to the oligo U sequences found in the 3' untranslated regions of many eukaryotic messenger RNAs (mRNA). The existence of such proteins would suggest that oligo U sequences share some common function in mRNAs. Such proteins would be identified initially by their binding to poly U dated to cytoplasmic extracts. If specific proteins are identified, their binding to the oligo U(+) mRNA population would be tested and ultimately binding to an oligo U containing mRNA such as beta-actin would be tested.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM032585-08
Application #
3281565
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1983-09-01
Project End
1992-08-31
Budget Start
1990-09-01
Budget End
1992-08-31
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Arts and Sciences
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Reilly, J D; Melhem, R F; Lutz, C M et al. (1990) Transcription vectors that facilitate the identification and mapping of RNA splice sites in genomic DNA. DNA Cell Biol 9:535-42
Reilly, J D; Wallace, J C; Edmonds, M (1987) The quantitation and distribution of splicing intermediates in HeLa cells and adenovirus RNAs. Nucleic Acids Res 15:7103-24
Kierzek, R; Kopp, D W; Edmonds, M et al. (1986) Chemical synthesis of branched RNA. Nucleic Acids Res 14:4751-64
Wood, W M; Wallace, J C; Edmonds, M (1985) Sequence content of oligo(uridylic acid)-containing messenger ribonucleic acid from HeLa cells. Biochemistry 24:3686-93
Kulkosky, J W; Wood, W M; Edmonds, M (1985) Location of oligo(uridylic acid) sequences within messenger ribonucleic acid molecules of HeLa cells. Biochemistry 24:3678-86